I've isolated one protein with lipase activity from streptomyces sp. and modeled it using homology modelling. After that, I studied insilico analysis (molecular docking) with type 2-diabetes drugs. My main aim was the enhancement of the lipase enzyme for type 2- diabetes via in silico modification through molecular modeling to predict the capability of the enzyme. Was my methodology correct? If not, I'd appreciate any suggestions!
Mohammed Hasanain
Diabetes 2 is different than diabetes one one of them is due to an lipid accumulation and other is due to hypersensitivity of leading to infectinfection one is fofor young other for old
0 votes
0 thanks
- Badges
- Science topic
- Similar topics
- Biological Science
- Biochemistry
- Enzymology
- Enzymes
More Dr. P. Praveen Kumar's questions See All
Similar questions and discussions